Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development
作者:Kerry E. Murphy-Benenato、Lakshmaiah Gingipalli、P. Ann Boriack-Sjodin、Gabriel Martinez-Botella、Dan Carcanague、Charles J. Eyermann、Madhu Gowravaram、Jenna Harang、Michael R. Hale、Georgine Ioannidis、Harris Jahic、Michele Johnstone、Amy Kutschke、Valerie A. Laganas、James T. Loch、Matthew D. Miller、Herbert Oguto、Sahil Joe Patel
DOI:10.1016/j.bmcl.2015.09.075
日期:2015.11
Two novel compounds, pyridopyrimidines (1) and naphthyridines (2) were identified as potent inhibitors of bacterial NAD(+)-dependent DNA ligase (Lig) A in a fragment screening. SAR was guided by molecular modeling and X-ray crystallography. It was observed that the diaminonitrile pharmacophore made a key interaction with the ligase enzyme, specifically residues Glu114, Lys291, and Leu117. Synthetic challenges limited opportunities for diversification of the naphthyridine core, therefore most of the SAR was focused on a pyridopyrimidine scaffold. The initial diversification at R-1 improved both enzyme and cell potency. Further SAR developed at the R-2 position using the Negishi cross-coupling reaction provided several compounds, among these compounds 22g showed good enzyme potency and cellular potency. (C) 2015 Elsevier Ltd. All rights reserved.